- 2 次围观
产品图片

货号/SKU
NR-45872
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质,其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类:美国、2
产品描述信息
NR-45872??Staphylococcus aureus, HIP07930(Bacteria)|Staphylococcus aureus|HIP07930|-60°C or colder|NARSAAcknowledgment for publications should read "The following reagent was provided by the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) for distribution by BEI Resources, NIAID, NIH: Staphylococcus aureus, Strain HIP07930, NR-45872."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Staphylococcus aureus (S. aureus), strain HIP07930 (also referred to as USA600, 99758 and NRS22) was isolated in 1999 from the bloodstream of an adult female ICU patient in New York, USA.
S. aureus, strain HIP07930 is a hosptial-acquired methicillin-resistant S. aureus (HA-MRSA) strain. Strain HIP07930 was deposited as resistant to erythromycin, clindamycin, trimethoprim/sulfamethoxazole, gentamicin and levofloxacin; positive for mec (subtype II); negative for PVL, tsst, sea, seb, sec, sed and see; MLST sequence type (ST) 45; pulsed-field type USA600; eGenomic spa type 10, eGenomic spa repeats A2AKEEMBKM; Ridom spa type t266; agr group I.S. aureus, strain HIP 07930 is a USA600 isolate. USA600 isolates have the same MLST profile (ST 45), SCCmec (subtype II or IV), agr group (I) and spa repeats (A2AKEEMBKB). They are PVL negative and resistant to erthromycin and clindamycin. Isolates are predominantly found in nares of healthy individuals and bloodstream infections. These isolates are associated with a higher rate of clinical failure and mortality, particularly those with a heterogeneous vancomycin-intermediate S. aureus (hVISA) phenotype. While USA600 isolates are uncommon the United States, the clonally-related Berlin strain is widespread throughout Germany, the Netherlands, and Ontario, Cananda.
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Staphylococcus aureus (S. aureus), strain HIP07930 (also referred to as USA600, 99758 and NRS22) was isolated in 1999 from the bloodstream of an adult female ICU patient in New York, USA.
S. aureus, strain HIP07930 is a hosptial-acquired methicillin-resistant S. aureus (HA-MRSA) strain. Strain HIP07930 was deposited as resistant to erythromycin, clindamycin, trimethoprim/sulfamethoxazole, gentamicin and levofloxacin; positive for mec (subtype II); negative for PVL, tsst, sea, seb, sec, sed and see; MLST sequence type (ST) 45; pulsed-field type USA600; eGenomic spa type 10, eGenomic spa repeats A2AKEEMBKM; Ridom spa type t266; agr group I.S. aureus, strain HIP 07930 is a USA600 isolate. USA600 isolates have the same MLST profile (ST 45), SCCmec (subtype II or IV), agr group (I) and spa repeats (A2AKEEMBKB). They are PVL negative and resistant to erthromycin and clindamycin. Isolates are predominantly found in nares of healthy individuals and bloodstream infections. These isolates are associated with a higher rate of clinical failure and mortality, particularly those with a heterogeneous vancomycin-intermediate S. aureus (hVISA) phenotype. While USA600 isolates are uncommon the United States, the clonally-related Berlin strain is widespread throughout Germany, the Netherlands, and Ontario, Cananda.
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
主要内容
此项目的每个订单数量限制为1.此项目每年可订购两次.在这一限制下订单将在发货前发送到NIAID进行批准. 金黄色葡萄球菌(金黄色葡萄球菌),菌株HIP07930(也称为USA600,99758和NRS22)于1999年从美国纽约成年女性ICU患者的血流中分离出来. S. AUREUS ,菌株HIP07930是一种沉积的甲氧基耐药性.金黄色葡萄球菌(HA-MRSA)菌株.将菌株HIP07930沉积为抗红霉素,Clindamycin,TrimethoLim /磺胺甲恶唑,庆大霉素和左氧氟沙星;阳性为 mec (亚型II); PV1的阴性, Tsst, Sea , SEB , SEC , SED 和看到; MLST序列类型(ST)45;脉冲场型USA600; Egenomic Spa 型10,eGenomic Spa 重复A2Akeembkm; ridom spa tys t266; agr 组I..金黄色葡萄球菌,菌株臀部07930是USA600分离物. USA600分离株具有相同的MLST谱(ST 45),SCC MEC (亚型II或IV), ARR 组(I)和 SPA 重复(a2akeembkb).它们是PVL阴性和抗壁霉素和克林霉素.分离物主要在健康个体和血流感染的鼻内发现.这些分离株与临床失败率和死亡率较高,特别是那些具有异质万古霉素中间体的临床失败和死亡率.金黄色葡萄球菌(HVISA)表型.虽然USA600孤立的孤立罕见的是美国,但克隆有关的柏林应变是普遍存在的德国,荷兰和安大略省的普遍存在的群体. 每个小瓶含有大约0.5毫升的胰蛋白酶肉汤中的细菌培养物补充有10 %甘油.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立,旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中,可以监控科学界对这些材料的访问和使用,并确保试剂的质量控制。
除了为传染病界提供材料外,BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势,包括安全存储、社区访问和分发;同时保护存款人的知识产权。只要有需要,BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月, ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料,包括由其他政府支持的研究项目存放的材料,将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中,涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识

可能感兴趣的内容
2022-04-01
2021-12-13
2024-06-05
2023-08-31
2022-04-01
2022-04-01
2022-04-01
2022-04-01
2024-08-04
2022-04-01
2024-01-21
2021-12-21
2022-04-01
2024-11-17
2022-03-22
2024-02-29
2021-12-21
2021-10-31